icon

CaroGen Highlights

icon

Developed novel AVIDIO platform that delivers multiple transgenes
Artificial Virus for Infectious Diseases & Immuno-Oncology

Base Line
icon

Two candidates in late stage pre-clinical (IND enabling) studies
CARG-2020 for ovarian cancer; CARG-201 for Chronic Hepatitis B

Base Line
icon

Broad and expanding patent portfolio
Issued composition of matter and methods of use patents

HBV program supported by over $10 million in NIH & DoD grants
Expect continued support for Phase 1 clinical studies

content-img
content-img
content-img
Our Team

Founders

founders-img

Bijan Almassian, phD

Chief Executive Officer

founders-img

Valerian Nakaar, PhD

Chief Scientific Officer

founders-img

John Rose, PhD

Chairman
Scientific Advisory Board

founders-img

Michael Robek, PhD

Member
Scientific Advisory Board

Our Press Releases

CaroGen News.

Our Press Releases

CaroGen News.